Weekend Reading
SEQH Capital Research Weekend Reading
Investment Intelligence for the Week Ahead | November 2, 2025
Macro Market Dynamics
The Federal Reserve delivered its second consecutive rate cut on Wednesday, lowering the federal funds rate by 25 basis points to 3.75%-4.00%, though Chairman Powell’s hawkish commentary significantly tempered expectations for further easing. Powell explicitly stated that a December rate cut is “not a foregone conclusion,” triggering immediate market volatility as traders slashed bets on additional cuts. The decision drew two dissents, Governor Miran favored a 50bp cut while Kansas City Fed President Schmid opposed any reduction.
Economic data reveals a complex landscape with Q2 GDP growth surging 3.8% following a -0.6% contraction in Q1. However, the labor market continues cooling, with the BLS reporting a record 911,000 downward revision to job growth estimates from March 2024-2025. October’s shutdown-delayed employment data adds uncertainty, though ADP’s private sector report showed concerning weakness.
Inflation remains problematic at 2.9% annually, above the Fed’s target, with core PCE estimated at 2.8%. The dollar’s strength and persistent geopolitical tensions, particularly escalating U.S.-China trade disputes following President Trump’s threatened 100% tariffs, create additional policy complexity.
Outlook: December FOMC meeting uncertainty suggests potential policy pause. Economic growth momentum faces headwinds from government shutdown effects and tightening financial conditions following Powell’s hawkish pivot.
Nuclear Energy Sector Update
Nuclear stocks maintained exceptional momentum this week, with the sector preparing for what analysts project could be the strongest year on record. The U.S. government’s $80 billion nuclear infrastructure deal has catalyzed significant institutional interest, positioning companies like Oklo (OKLO), which surged over 526% year-to-date, as key beneficiaries.
Top performers include NuScale Power (SMR), BWX Technologies (BWXT), and Centrus Energy (LEU), with the latter gaining over 501% in 2025. Cameco (CCJ) and Constellation Energy (CEG) continue benefiting from higher uranium prices and strategic data center partnerships, including Meta’s 20-year nuclear power agreement with Constellation.
Uranium fundamentals remain robust with spot prices reaching $82.40/lb, up 4.63% year-over-year despite recent monthly softness. Supply constraints persist as Cameco cut annual production guidance due to McArthur mine delays, while Kazakhstan’s Kazatomprom reduced 2026 output by 10%. The World Nuclear Association forecasts uranium demand rising 28% by 2030, supporting structural price support.
Global nuclear capacity additions accelerated with 70 reactors under construction, 59 located in Asia. The sector achieved record electricity generation of 2,667 TWh in 2024, avoiding 2.1 billion tonnes of CO2 emissions.
Outlook: Nuclear renaissance continues driven by AI data center demand, decarbonization mandates, and supply-demand imbalances. December policy announcements and Q4 earnings should provide additional catalysts.
Healthcare Sector Performance
Healthcare demonstrated defensive characteristics amid mixed market conditions, with the S&P 500 Healthcare Sector tracking broader uncertainty rather than sector-specific catalysts. Q3 earnings season delivered mixed results, with 87.5% of reporting companies beating earnings expectations and revenue projections.
FDA approvals accelerated in October with key oncology decisions including revumenib for acute myeloid leukemia and belantamab mafodotin-blmf for multiple myeloma. Regeneron’s Libtayo received adjuvant approval for cutaneous squamous cell carcinoma, while Jazz Pharmaceuticals secured approvals for multiple cancer indications.
Gilead Sciences (GILD) reported strong Q3 results with $2.43 EPS versus $1.00 prior year, driven by higher HIV sales offsetting Veklury declines. However, sector leadership remains fragmented with biotech names hitting 52-week highs while established players face patent cliff pressures.
Top healthcare performers year-to-date include McKesson Corporation (+55.85%), Cencora Inc (+58.10%), and Cardinal Health (+43.76%). Alnylam Pharmaceuticals raised guidance on strong ATTR-CM launch momentum.
Outlook: Defensive positioning likely continues amid macro uncertainty. Q4 FDA calendar remains robust with multiple high-value approvals pending. Medicare Advantage headwinds and biosimilar competition present sector headwinds.
Bitcoin & Crypto Equities Analysis
Bitcoin’s historic “Uptober” streak ended for the first time since 2018, declining 3.6% in October to current levels around $110,000. The break from seasonal patterns reflects $19 billion in liquidations, trade war escalation, and Fed policy uncertainty. Despite October’s disappointment, Bitcoin maintains massive 2025 gains and November historically represents the strongest month with 42.5% average returns.
Mining stocks demonstrated notable resilience and diversification strategies. CleanSpark (CLSK) emerged as the standout performer with 87% year-to-date returns despite holding just 13,011 bitcoins compared to MicroStrategy’s 640,250. The company’s momentum score reached 91.89 with a growth rating of 99.61, driven by operational excellence and AI pivot strategies.
Jane Street Capital’s disclosure of significant stakes in bitcoin miners, 5% in 8i Enterprises, 5.4% in Bit Digital, and 5% in Cipher Mining, triggered sector-wide rallies. TeraWulf (WULF) jumped 25% on AI partnership announcements, while multiple miners including Marathon Digital and Riot Platforms pivoted toward high-performance computing.
MicroStrategy (MSTR) faced pressure, declining 13% monthly as premium valuations and bitcoin volatility weighed on performance. The company maintains ambitious $150,000 bitcoin price targets for year-end, though current levels suggest challenging execution.
Outlook: November seasonality supports potential recovery, though $19B liquidation overhang remains. Mining sector diversification into AI/HPC provides operational leverage beyond bitcoin price correlation.
Metals & Mining Sector Spotlight
Precious metals delivered spectacular 2025 performance with gold advancing 57% to above $4,100/oz and silver surging 78% to $51.5/oz. Gold mining stocks positioned for their strongest year ever, with STOXX global mining indices gaining 126% year-to-date. Top gold performers include Coeur Mining (CDE) +58.4%, Hecla Mining (HL) +47.7%, and McEwen Mining (MUX) +42.3%.
Industrial metals showed mixed performance with copper rising to $5.09/lb, up 17.69% year-over-year, supported by supply disruptions from Indonesia’s Grasberg mine force majeure. Lithium prices stabilized at 80,550 CNY/T, up 11.10% annually, though specialty commodity financing dropped 60% month-over-month.
Mining sector fundamentals remain challenged by operational headwinds, as evidenced by B2Gold’s (BTG) significant price gap-down following Goose Mine commissioning issues. However, record gold prices supported exceptional earnings, with Newmont (NEM) reporting record quarterly cash flow and 12x trailing P/E ratio despite substantial share price gains.
CME Group reported record precious metals futures activity with Micro Gold achieving 312,831 contract average daily volume in September, the second-highest monthly record. Physical demand remains robust from central banks and investment flows.
Outlook: Precious metals momentum likely continues on monetary policy uncertainty and geopolitical tensions. Industrial metals face China demand concerns offset by supply constraints. Mining equity valuations remain attractive despite year-to-date gains.
Week Ahead: Key Catalysts
Earnings: High-impact releases include Palantir (PLTR), AMD, Uber (UBER), and Robinhood (HOOD) Monday; Airbnb (ABNB) and Block (SQ) Wednesday. Nuclear plays Cameco and uranium miners report throughout the week.
Economic Data: ISM Manufacturing PMI Monday, JOLTS data Tuesday, and potential employment data releases pending shutdown resolution. Fed speakers including Governor Waller may provide December meeting clarity.
Policy Events: OPEC+ meeting Sunday could impact energy markets, while ongoing government shutdown resolution remains critical for data flow normalization.
Technical Levels: Bitcoin testing $110K support, gold holding above $4,000/oz, and 10-year Treasury yields at critical inflection points following Fed communication.
This analysis reflects conditions as of November 2, 2025, and is prepared for institutional clients of SEQH Capital Research. Past performance does not guarantee future results.